NasdaqGM - Nasdaq Real Time Price USD
NewAmsterdam Pharma Company N.V. (NAMS)
20.21
-0.82
(-3.90%)
At close: June 13 at 4:00:00 PM EDT
20.21
0.00
(0.00%)
After hours: June 13 at 5:50:41 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-140,430
-158,564
-141,218
10,665
-29,512
Investing Cash Flow
-59,608
-62,848
-24
-221
-24
Financing Cash Flow
467,846
659,507
8,912
391,905
84,704
End Cash Position
748,955
771,743
340,450
467,728
60,131
Income Tax Paid Supplemental Data
--
1
27
0
0
Interest Paid Supplemental Data
--
0
0
277
0
Capital Expenditure
-303
-672
-24
-221
-24
Issuance of Capital Stock
455,026
645,507
0
396,952
84,704
Issuance of Debt
--
0
0
747
0
Repayment of Debt
-43
--
--
-69.71
-11.32
Free Cash Flow
-140,733
-159,236
-141,242
10,444
-29,536
12/31/2021 - 2/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LEGN Legend Biotech Corporation
36.83
-2.85%
NKTR Nektar Therapeutics
8.59
-1.94%
INSM Insmed Incorporated
98.73
+1.91%
RNA Avidity Biosciences, Inc.
31.37
-2.40%
MTSR Metsera, Inc.
29.38
-15.04%
ZLAB Zai Lab Limited
41.00
-4.72%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
APGE Apogee Therapeutics, Inc.
44.48
+6.26%
LYEL Lyell Immunopharma, Inc.
9.74
0.00%
VRNA Verona Pharma plc
92.20
-0.32%